Medical School and Year of Graduation
Istanbul University Faculty of Medicine - 2001
Place and Year of Specialty Training
Istanbul University Faculty of Medicine - 2008
Professional Experience
Dr., Research Assistant - Istanbul University Faculty of Medicine, Department of Internal Medicine 2002-2008
Specialist Dr., Research Assistant - Izmir Atatürk Training and Research Hospital, Medical Oncology Clinic 2009-2012
Specialist Dr. - Aydın Atatürk State Hospital 2013-2014
Assoc. Prof. Dr. - Medical Park Trabzon Hospital 2015-2016
Assoc. Prof. Dr. - Eskişehir Osmangazi University Faculty of Medicine, Internal Medicine / Medical Oncology 2016-2021
Medical Interests
• Targeted therapy
• Immunotherapy
• Chemotherapy
• Personalized treatment in cancer
Special Procedures
Scientific Publications
PUBLICATIONS
A. Articles published in international peer-reviewed journals:
A1. Demir L, Somali I, Oktay Tarhan M, Erten C, Ellidokuz H, Can A, Dirican A, Vedat Bayoglu I. The toxicity and efficacy of Nordic-FLOX regimen as adjuvant treatment of stage III colon cancer. J BUON 2011;16(4):682-8.
A2. Demir L, Erten C, Yigit SC, Can A, Dirican A, Bayoglu V, Kucukzeybek Y, Somali I, Tarhan MO. Intramammary lymph node metastasis in a patient with ovarian carcinoma and a brief review of the literature. Contemp Oncol (Pozn). 2012;16(2):108-10.
A3. Yigit S, Demir L, Tarhan MO, Cabuk FK, Ellidokuz H, Erten C, Somali I, Dirican A, Cakalagaoglu F. The clinicopathological significance of Bax and Bcl-2 protein expression with tumor infiltrating lymphocytes in ovarian carcinoma. Neoplasma2012;59(5):475-85.
A4. Demir L, Can A, Dirican A, Bayoğlu V, Rezanko TA, Akyol M, Kucukzeybek Y, Erten C, Tarhan MO. Malignant fibrous histiocytoma of the spermatic cord in a patient with polycystic kidney disease; review of the literature. Clin Genitourin Cancer. 2012;10(4):280-3.
A5. Kaplan MA, Isikdogan A, Koca D, Kucukoner M, Gumusay O, Yildiz R, Dayan A, Demir L, Geredeli C, Kocer M, Arslan UY, Inal A, Unal OU, Mert AG, Bilici M, Ozkan M, Elkiran ET, Yaman S, Durnalı AG, Suner A, Alici S, Tarhan MO, Boruban C, Urakci Z, Buyukberber S. Biological subtypes and survival outcomes in breast cancer patients with brain metastases (study of the Anatolian Society of Medical Oncology). Oncology. 2012;83(3):141-50.
A6. Demir L, Erten C, Somali I, Can A, Dirican A, Bayoglu V, Kucukzeybek Y, Altinboga AA, Ermete M, Oztop RM, Tarhan MO. Metastases of renal cell carcinoma to the larynx and thyroid: Two case reports on metastasis developing years after nephrectomy. Can Urol Assoc J. 2012;6(5):E209-12.
A7. Kucukzeybek Y, Dirican A, Erten C, Somali I, Can A, Demir L, Bayoglu IV, Akyol M, Medeni M, Tarhan MO. Second-line irinotecan after cisplatin, fluoropyrimidin and docetaxel for chemotherapy of metastatic gastric cancer. Asian Pac J Cancer Prev. 2012;13(6):2771-4.
A8. Kamali S, Artim-Esen B, Erer B, Ozdener L, Gul A, Ocal L, Aral O, Inanc M. Re-evaluation of 129 patients with systemic necrotizing vasculitides by using classification algorithm according to consensus methodology. Clin Rheumatol. 2012;31(2):325-8.
A9. Kaplan MA, Isikdogan A, Koca D, Kucukoner M, Gumusay O, Yildiz R, Dayan A, Demir L, Geredeli C, Kocer M, Arslan UY, Inal A, Akman T, Coskun U, Sener N, Inanc M, Elkiran ET, Ozdemir NY, Durnalı AG, Suner A, Alici S, Tarhan MO, Boruban C, Oksuzoglu B, Urakci Z. Clinical outcomes in patients who received lapatinib plus capecitabine combination therapy for HER2-positive breast cancer with brain metastasis and a comparison of survival with those who received trastuzumab-based therapy: a study by the Anatolian Society of Medical Oncology. Breast Cancer. 2013 DOI: 10.1007/s12282-013-0441-y.
A10. Demir L, Can A, Oztop R, Dirican A, Bayoglu V, Akyol M, Kucukzeybek Y, Erten C, Somali I, Tarhan MO. Malignant epithelioid hemangioendothelioma progressing after chemotherapy and Interferon treatment: a case presentation and a brief review of the literature. J Cancer Res Ther. 2013;9(1):125-7.
A11. Tarhan MO, Demir L, Somali I, Yigit S, Erten C, Alacacioglu A, Ellidokuz H, Seseogullari O, Kucukzeybek Y, Can A, Dirican A, Bayoglu V, Akyol M. The clinicopathological evaluation of the breast cancer patients with brain metastases: predictors of survival. Clin Exp Metastasis. 2013;30(2):201-13.
A12. Dirican A, Küçükzeybek Y, Somalι I, Erten C, Demir L, Can A, Bayoğlu IV, Ermete M, Altιnboğa AA, Tarhan MO. Cutaneous and subcutaneous metastases from bladder carcinoma. Contemp Oncol (Pozn). 2012;16(5):451-2.
A13. Tarhan MO, Gonel A, Kucukzeybek Y, Erten C, Cuhadar S, Yigit SC, Atay A, Somali I, Dirican A, Demir L, Koseoglu M. Prognostic significance of circulating tumor cells and serum CA15-3 levels in metastatic breast cancer, single center experience, preliminary results. Asian Pac J Cancer Prev. 2013;14(3):1725-9.
A14. Dirican A, Ekinci N, Avci A, Akyol M, Alacacioglu A, Kucukzeybek Y, Somali I, Erten C, Demir L, Can A, Bayoglu IV, Koyuncu B, Tarhan MO. Prognostic and Predictive Value of Hematologic Parameters in Patients with Metastatic Renal Cell Cancer: Second Line Sunitinib Treatment Following IFN-alpha; Preliminary Study. Asian Pacific Journal of Cancer Prevention 2013;14(3):2101-5.
A15. Dirican A, Ekinci N, Avci A, Akyol M, Alacacioglu A, Kucukzeybek Y, Somali I, Erten C, Demir L, Can A, Bayoglu IV, Koyuncu B, Tarhan MO. The Effects of Hematological Parameters and Tumor-Infiltrating Lymphocytes on Prognosis in Patients with Gastric Cancer. Cancer Biomarkers 2013 1;13(1):11-20.
A16. Dirican A, Kucukzeybek Z, Tarhan MO, Somali I, Erten C, Demir L, Can A, Bayoglu V, Akyol M, Ekinci N, Medeni M, Alacacioglu A. One-Day DCF Regimen in Patients with Metastatic Gastric Cancer. Tumori 2013;99:145-148.
A17. Demir L, Yigit S, Ellidokuz H, Erten C, Somali I, Kucukzeybek Y, Alacacioglu A, Cokmert S, Can A, Akyol M, Dirican A, Bayoglu V, Sari AA, Tarhan MO. Predictive and prognostic factors in locally advanced breast cancer: effect of intratumoral FOXP3+ Tregs. Clinical Experimantal Metastasis 2013;30(8):1047-1062.
A18. Erten C, Demir L, Somali I, Alacacioglu A, Kucukzeybek Y, Akyol M, Can A, Dirican A, Bayoglu V, Tarhan MO. Cisplatin plus gemcitabine for treatment of breast cancer patients with brain metastases; is it a preferential option for triple negative patients?. Asian Pacific Journal of Cancer Prevention 2013;14(6):3711-3717.
A19. Demir L, Ekinci N, Erten C, Kucukzeybek Y, Alacacioglu A, Somali I, Can A, Dirican A, Bayoglu V, Akyol M, Cakalagaoglu F, Tarhan MO. Does Immunohistochemistry Provide Additional Prognostic Data in Gastrointestinal Stromal Tumors? Asian Pacific Journal of Cancer Prevention 2013;14(8):4751-4758.
A20. Somali I, Ustaoglu BY, Tarhan MO, Yigit SC, Demir L, Ellidokuz H, Erten C, Alacacioglu A. Clinicopathologic and Demographic Evaluation of Triple-Negative Breast Cancer Patients among a Turkish Patient Population: a Single Center Experience. Asian Pacific Journal of Cancer Prevention 2013;14(10):6013-6017.
A21. Can A, Alacacioglu A, Kucukzeybek Y, Erten C, Cokmert S, Demir L, Dirican A, Bayoglu V, Akyol M, Aslan F, Tarhan MO. The relationship of insulin resistance and metabolic syndrome with known breast prognostic factors in postmenapausal breast cancer patients. J. BUON 2013;18(4):845-850.
A22. Cokmert S, Demir L, Akder Sari A, Kucukzeybek Y, Can A, Akyol M, Bayoglu IV, Dirican A, Erten C, Tarhan MO. Synchronous appearance of a high-grade neuroendocrine carcinoma of the ampulla vater and sigmoid colon adenocarcinoma. Case Rep Oncol Med. 2013;2013:930359. doi: 10.1155/2013/930359.
A23. Kuşku Cabuk F, Yığıt S, Demır L, Cakalağaoğlu F, Tarhan O. Correlation of survivin and MMP9 expressions with prognosis and clinicopathological parameters in surface epithelial ovarian carcinomas. Turk Patoloji Derg. 2014;30(1):30-7.
A24. Cokmert S, Demir L, Akyol M, Bayoglu IV, Can A, Unek IT, Bolat FA. Clitoris metastasis from a retroperitoneal leiomyosarcoma: A case report. World J Clin Oncol. 2014;5(1):28-32.
A25. Dirican A, Levent F, Alacacioglu A, Kucukzeybek Y, Varol U, Kocabas U, Senöz O, Emren SX, Demir L, Coban E, Aksun S, Sutcu R, Tarhan MO. Acute Cardiotoxic Effects of Adjuvant Trastuzumab Treatment and Its Relation to Oxidative Stress. Angiology, 2014. doi: 10.1177/0003319714523112.
A26. Dirican A, Kucukzeybek Y, Alacacioglu A, Varol U, Aksun S, Bayoglu IV, Demir L, Coban E, Sutcu R, Tarhan MO. Impact of pre-angiogenic factors on the treatment effect of bevacizumab in patients with metastatic colorectal cancer. Med Oncol. 2014;31(4):905.
A27. Cokmert S, Demir L, Can A, Akyol M, Vedat Bayoglu I, Dirican A, Kucukzeybek Y, Erten C, Oktay Tarhan M. Capecitabine-related increased mean corpuscular volume of red blood cell may be a predictive marker of treatment response and survival in patients with metastatic colorectal cancer. J BUON. 2014 Jan-Mar;19(1):75-82.
A28. Dirican A, Kucukzeybek Z, Somali I, Erten C, Demir L, Can A, Payzin B, Bayoglu V, Akyol M, Koseoglu M, Alacacioglu A, Tarhan MO, The association of hematologic parameters on prognosis of patients with metastatic renal cell carcinoma. J BUON 2013;18(2):413-419.
A29. Dirican A, Kucukzeybek Y, Somali I, Erten C, Demir L, Can A, Bayoglu IV, Yigit SC, Unay FC, Yetimalar MH, Tarhan MO. Micro-metastases into the uterine leiomyoma from invasive ductal breast cancer under adjuvant tamoxifen therapy: case report. Eur J Gynaecol Oncol. 2012;33(6):652-5.
A30. Akyol M, Demir L, Dirican A, Ekinci N, Can A, Bayoglu V, Alacacioglu A, Kucukzeybek Y, Cokmert S, Erten C, Cakalagaoglu F, Tarhan MO. Skin and maxillary sinus involvement of colon cancer. Contemp Oncol (Pozn). 2014;18(1):70-2
A31. Demir L, Yigit S, Sadullahoglu C, Akyol M, Cokmert S, Kucukzeybek Y, Alacacioglu A, Cakalagaoglu F, Tarhan MO. Hormone Receptor, HER2/NEU and EGFR Expression in Ovarian Carcinoma - is here a Prognostic Phenotype? Asian Pac J Cancer Prev. 2014;15:9739-45.
A32. Alacacioglu A, Ulger E, Varol U, Yildiz I, Salman T, Bayoglu V, Dirican A, Demir L, Akyol M, Yildiz Y, Kucukzeybek Y, Ataman G, Can H, Alacacioglu I, Tarhan MO. Depression, anxiety and sexual satisfaction in breast cancer patients and their partners-Izmir oncology group study. Asian Pac J Cancer Prev 2014;15:10631-6.
A33. Alacacioglu A, Ulger E, Varol U, Yavuzsen T, Akyol M, Yildiz Y, Yildiz I, Bayoglu V, Dirican A, Demir L, Salman T, Kucukzeybek Y, Alacacioglu I, Can H, Tarhan MO. Sexual satisfaction, anxiety, depression and quality of life in testicular cancer survivors. Med Oncol. 2014;31(7):43.
A34. Bayoglu IV, Kucukzeybek BB, Kucukzeybek Y, Varol U, Yildiz I, Alacacioglu A, Akyol M, Demir L, Dirican A, Yildiz Y, Salman T, Tarhan MO. Prognostic value of mesothelin expression in patients with triple negative and HER2-positive breast cancers. Biomed Pharmacother. 2015;70:190-5.
A35. Vedat Bayoglu I, Yildiz I, Varol U, Cokmert S, Kucukzeybek Y, Alacacioglu A, Demir L, Dirican A, Akyol M, Yildiz Y, Oktay Tarhan M.Comparison of first-line bevacizumab in combination with mFOLFOX6 or XELOX in metastatic colorectal cancer.
J BUON 2015;20(2):460-7.
A36. Cokmert S, Ellidokuz H, Demir L, Fuzun M, Astarcioglu I, Aslan D, Yilmaz U, Oztop I. Survival outcomes of liver metastasectomy in colorectal cancer cases: a single-center analysis in Turkey.Asian Pac J Cancer Prev. 2014;15(13):5195-200.
A37. Kucukzeybek Y, Dirican A, Demir L, Yildirim S, Akyol M, Yildiz Y, Bayoglu IV, Alacacioglu A, Varol U, Salman T, Yildiz I, Can H, Tarhan MO.Adjuvant Chemotherapy and Prognostic Factors in Stage II Colon Cancer - Izmir Oncology Group Study. Asian Pac J Cancer Prev. 2015;16(6):2413-8.
A38. Akyol M, Ulger E, Alacacioglu A, Kucukzeybek Y, Bayoglu V, Yildiz Y, Yildiz I, Salman T, Varol U,Demir L, Dirican A, Gumus Z, Oktay Tarhan M.Quality of life in colorectal cancer patients: an Izmir Oncology Group (IZOG) study. J BUON 2015;20(4):1015-22.
A39. Demir L, Akyol M, Bener S, Payzin KB, Erten C, Somali I, Can A, Dirican A, Bayoglu V, Kucukzeybek Y, Alacacioglu A, Calli AO, Tarhan MO. Prognostic evaluation of breast cancer patients with evident bone marrow metastasis. Breast J. 2014;20(3):279-87.
A40. Bayoglu IV, Varol U, Yildiz I, Muslu U, Alacacioglu A, Kucukzeybek Y, Akyol M, Demir L, Dirican A, Cokmert S, Yildiz Y, Karabulut B, Uslu R, Tarhan MO.Second-line capecitabine and oxaliplatin combination for gemcitabine-resistant advanced pancreatic cancer. Asian Pac J Cancer Prev. 2014;15(17):7119-23.
A41. Oktay E, Oflazoglu U, Varol Y, Tanriverdi O, Mermur N, Arda HU, Demir L, Keskin O, Ahmadli T, Somali I, Oztop I, Meydan N. The prognostic role of thyroid transcription factor-1 in lung adenocarcinoma. J Cancer Res Ther. 2018;14(Supplement):S1201-S1208.
A42. Dural M, Demir L, Babayiğit E, Junushova B, Mert KU, Ulus T, Çavuşoğlu Y, Yıldız B, Dinçer M, Görenek B. Fragmented QRS formation and its predictors in patients with breast cancer receiving anthracycline-based chemotherapy. J Electrocardiol. 2019;54:5-9.
A43. Cokmert S, Tanriverdi O, Karapolat I, Demir L, Bayoglu V, Can A, Akyol M, Yilmaz Y, Oktay Tarhan M. The maximum standardized uptake value of metastatic site in 18 F-FDG PET/CT predicts molecular subtypes and survival in metastatic breast cancer: An Izmir Oncology Group study. J BUON. 2016;21(6):1410-1418.
A44. Bayoglu İV, Yildiz I, Varol U, Cokmert S, Alacacıoğlu A, Kucukzeybek Y, Akyol M, Demir L, Dirican A, Tarhan O. Uracil/tegafur as a possible salvage therapy in chemo-refractory colorectal cancer patients: a single institutional retrospective study. Contemp Oncol (Pozn). 2015;19(5):385-90.
A45. Dirican A, Varol U, Kucukzeybek Y, Alacacioglu A, Erten C, Somali I, Can A, Demir L, Bayoglu IV, Akyol M, Yildiz Y, Koyuncu B, Coban E, Tarhan MO. Treatment of metastatic colorectal cancer with or without bevacizumab: can the neutrophil/lymphocyte ratio predict the efficiency of bevacizumab? Asian Pac J Cancer Prev. 2014;15(12):4781-6.
A46. Akyol M, Demir L, Alacacioglu A, Ellidokuz H, Kucukzeybek Y, Yildiz Y, Gumus Z, Bayoglu V, Yildiz I, Salman T, Varol U, Kucukzeybek B, Demir L, Dirican A, Sutcu R, Tarhan MO. The Effects of Adjuvant Endocrine Treatment on Serum Leptin, Serum Adiponectin and Body Composition in Patients with Breast Cancer: The Izmir Oncology Group (IZOG) Study. Chemotherapy 2015;61(2):57-64.
A47. Demir L, Ekinci N, Erten C, Somali I, Can A, Dirican A, Cokmert S, Bayoglu V, Akyol M, Kucukzeybek Y, Alacacioglu A, Tarhan MO. The impact of cell proliferation markers and p53 mutation status on prognosis of non-metastatic colon cancer. J Surg Oncol. 2014;109(7):665-75.
A48. Dirican A, Kucukzeybek BB, Alacacioglu A, Kucukzeybek Y, Erten C, Varol U, Somali I, Demir L, Bayoglu IV, Yildiz Y, Akyol M, Koyuncu B, Coban E, Ulger E, Unay FC, Tarhan MO. Do the derived neutrophil to lymphocyte ratio and the neutrophil to lymphocyte ratio predict prognosis in breast cancer? Int J Clin Oncol. 2014.
A49. Demir L, Bayir D, Ozdogan R, Yildiz B, Dincer M. A real-world comparison of Pazopanib versus Sunitinib in Metastatic Renal Cell Carcinoma: Focus on poor-risk patients, a single-center study. J Oncol sci. 2020;6(3):153-163.
A50. Akyol M, Varol U, Yildiz I, Bayoglu IV, Yildiz Y, Demir L, Dirican A, Can A, Cokmert S, Oztop MT, Alacacioglu A, Kucukzeybek Y, Tarhan MO. Isolated liver metastasis of sacrococcygeal chordoma: case report and review of the literature. Case Rep Oncol Med. 2014;2014:826584.
A51. Cokmert S, Demir L, Doganay L, Demir N, Kocacelebi K, Unek IT, Gezer E, Kilic K, Alakavuklar M. Large Cell Neuroendocrine Carcinoma of the Ovary and Its Skin Metastases: A Case Report and Review of the Literature. West Indian Med J. 2014;63(6).
B. Papers presented at international scientific meetings and published in the proceedings book (Proceedings):
Poster presentations
B1. Yigit S, Demir L, Cabuk FK, Tarhan O, Ellidokuz H, Erten C, Somali I. Clinicopathological significance of Bcl-2 and Bax proteins expression in primary ovarian carcinomas.Virchows Archiv, The European Journal of Pathology, Volume 459 (Suppl 1), 259pp. 23.European Congress of Pathology, Helsinki, Finlandiya, 2011.
B2. Kaplan MA, Isikdogan A, Koca D, Kucukoner M, Gumusay O, Yıldız R, Dayan A, Demir L, Geredeli C, Kocer M, Arslan UY, İnal A, Akman T, Coskun U, Sener N, İnanc M, Elkiran ET, Ozdemir NY, Durnali AG, Suner A, Alici S, Tarhan MO, Boruban C, Oksuzoglu B, Urakci Z. Lapatinib or trastuzumab? which anti-HER2 treatment is more effective in the treatment of HER2-positive breast cancer patients with brain metastasis? ( An Anatolian Society of Medical Oncology Study). J Clin Oncol, Volume 30, 2012 (suppl; abstract 638). ASCO Annual Meeting, Chicago, 2012.
B3. Demir L, Yigit S, Sari A, Etit D, Avci A, Tarhan MO, Cakalagaoglu F. CD68 expression in locally advanced breast carcinoma association with clinicopathological parameters and survival. Modern Pathology, Volume 27 (Suppl 2), 43-44 pp. 103. USCAP, California, 2014.
B4. Bayoglu IV, Kucukzeybek B, Kucukzeybek Y, Yildiz I, Akyol M, Varol U, Alacacioglu A, Demir L, Dirican A, Yildiz Y, Tarhan MO. Expression and prognostic significance of mesothelin in HER2 positive and triple negative breast cancer patients. Ann Oncol 2014; 25(4): 564-573.
B5. Akyol M, Demir L, Alacacioglu A, Ellidokuz H, Kucukzeybek Y, Yildiz Y, Bayoglu V, Yildiz I, Salman T, Varol U, Kucukzeybek B, Demir L, Dirican A, Sutcu R, Tarhan O. The effects of adjuvant endocrine treatment on the serum leptin, adiponectin and body composition in patients with breast cancer [Izmir Oncology Group(IZOG) Study] . 2015 European Cancer Congress, supplement 3, S317, Poster number: 1953
B6. Bayoglu IV, Kurtel G, Alacacioglu A, Varim C, Yildiz I, Kucukzeybek Y, Dirican A, Demir L, Yildiz Y, Akyol M, Tarhan MO. Can basal neutrophil/lymphocytes ratio predict clinical outcome of melanoma patients? ASCO 2015 congress, poster presentation, Journal of clinical Oncology volume 33, issue 15
Oral presentations
B7. Karateke YS, Demir L, Yıldız B, Dinçer M. Malignant Melanoma: Clinicopathological feautres and prognostic significance of neutrophil-lymphocyte ratio .(oral presentation) S-005 3. National Immunotherapy and Oncology Congress (30 Octy-3 Nov 2019) Antalya
B8. Cokmert S, Altun Z, Aktaş S, Ünlü GD, Ayaz D, Kahraman DS, Demir L, Değirmenci M. The evaluation of expressions of immune markers in colorectal cancer patients. OP 271. 2nd International Medical Congress of Izmir Democracy University. IMCIDU 2020. 17-19 December Izmir
C. International books or book chapters authored:
Book Translation
C1. Handbook of Cancer Chemotherapy. Roland T. Skeel, Samir N. Khleif (Editors); Prof. Dr. Haluk Onat (Translation Editor). Chapter 27, Infections: Etiology, Treatment and Prevention. Thomas J. Walsch, Joan M. Duggan (Chapter authors) Specialist Dr. Lütfiye Demir (Translator), 566-595 pp., Çukurova Nobel Tıp Kitabevi, ADANA 2013.
C2. Handbook of Cancer Chemotherapy. Roland T. Skeel, Samir N. Khleif (Editors); Prof. Dr. Haluk Onat (Translation Editor). Chapter 26, Side Effects of Chemotherapy and Targeted Agents. Janelle M. Tipton (Chapter Authors) Specialist Dr. Lütfiye Demir (Translator), 543-566 pp., Çukurova Tıp Yayınevi, ADANA, 2013.
C3. Demir L, Dal P. Endometrial Cancer. Devita Hellman, and Rosenberg's Cancer Principles&Practice of Oncology Turkish 10th edition translation, Translation editors: Mehmet Ali Özcan, Ahmet Alacacıoğlu. O'TIP KİTABEVİ. 2018, Chapter 73. p:1094-1111
C4. Demir L, Dal P. Genetic tests in uterine cancer. Devita Hellman, and Rosenberg's Cancer Principles&Practice of Oncology Turkish 10th edition translation, Translation editors: Mehmet Ali Özcan, Ahmet Alacacıoğlu. O'TIP KİTABEVİ. 2018, Chapter 74. p:1112-1116
C5. Demir L, Aliyev A. Molecular biology of gynecologic cancers. Devita Hellman, and Rosenberg's Cancer Principles&Practice of Oncology Turkish 10th edition translation, Translation editors: Mehmet Ali Özcan, Ahmet Alacacıoğlu. O'TIP KİTABEVİ. 2018, Chapter 71. p:1049-1057
C6. Demir L, Aliyev A. Cancer of the cervix, vagina and vulva. Devita Hellman, and Rosenberg's Cancer Principles&Practice of Oncology Turkish 10th edition translation, Translation editors: Mehmet Ali Özcan, Ahmet Alacacıoğlu. O'TIP KİTABEVİ. 2018, Chapter 72. p:1058—1093
National Book Chapter
C7. Demir N, Demir L. Adnexal tumors of the skin. Cutaneous Adnexal Tumors. Dincer M, editor. Rare Tumors. 1st edition. Ankara: Türkiye Klinikleri;2020. p166-170.
C8. Demir L. Systemic treatment in ovarian cancer. Özdemir F, editor. Gynecologic Cancers. 1st Edition. Ankara: Türkiye Klinikleri; 2019. p. 52-66.
C9. Demir L. Cancer and Thrombosis. Korkmaz C, editor. Thrombophilia from the Perspective of Internal Medicine. Eskişehir Osmangazi University Publications, Eskişehir. 2019; chapter E, p: 107-119.
C10. Demir L. Breast examination. Akalın A, Bilge ŞY, Yıldız P, editors. Patient Assessment Guide in Internal Medicine. Eskişehir Osmangazi University Publications, Eskişehir. 2019. Chapter v.5.4 p:73-78.
C11. Demir L. Lymphomas and Myeloma: Treatment and Approach. Mandel NM, editor. Handbook of Oncology. Çukurova Nobel Tıp Kitabevi, Adana. 2015; Topic 13: page :355-382.
D. Articles published in national peer-reviewed journals:
D1. Erden S, Sakar S, Koc Z, Sen F, Cakir H, Gelincik A, Kilic L, Ozdener L. The Properties of Vitamin B12 Deficiency in the Patients of an Outpatient Clinic. Turkiye Klinikleri J Med Sci 2010;30(6):1845-51.
D2. Demir L, Rezanko T, Akyol M, Bayoglu V, Dirican A, Can A, Cokmert S, Kucukzeybek Y, Alacacioglu A, Erten C, Somali I, Tarhan MO. Malignant hemangiopericytoma; report of two cases wıth different behaviour and review of literature. Türkiye Klinikleri Journal of Medical Research-Case Reports 2013;21(1):18-24.
D3. Dirican A, Kucukzeybek Z, Tarhan MO, Somali I, Erten C, Demir L, Can A, Bayoglu V, Akyol M, Ekinci N, Medeni M, Alacacioglu A. Induction or Adjuvant Docetaxel/Cisplatin Chemotherapy in Advanced Non-Metastatic Nasopharyngeal Cancer. Kocatepe Medical Journal 2014;15(1):92-8.
D4. Akyol M, Küçükzeybek Y, Varol U, Yıldız İ, Çokmert S, Bayoğlu İV, Yıldız Y, Demir L, Can A, Dirican A, Alacacıoğlu A, Tarhan MO. First-line bolus 5-Fluorouracil and cisplatin combination in patients with locally advanced and metastatic esophageal cancer (Izmir Oncology Group Study). Acta Oncologica Turcica 2015;48(1):20-26
D5. Acar T, Kamer KE, Demir L, Tarcan E, Gür EÖ, Atahan MK, Tarhan MO, Acar N. Factors affecting disease-free and overall survival after neoadjuvant chemotherapy in patients with locally advanced breast cancer. J Surg Arts (Cer San D),2020;13(1):1-10.
D6. Emekli E, Toprak U, Şaylısoy S, Demir L. A rare case of extraosseous Ewing sarcoma of the nape of the neck. Ortadogu Medical Jorunal 2019;11(4):626-630.
D7. Karateke YS, Demir L. Management of adverse effects developing after Dabrafenib-Trametinib combination therapy in BRAF-mutant metastatic melanoma: A literature review with two case reports. Osmangazi Journal Of Medicine, 2020. https://doi.org/10.20515/otd.690957
D8. Küçükzeybek Y, Akyol M, Bayoğlu İV, Can A, Dirican A, Alacacıoğlu A, Erten Ç, Demir L, Çokmert S, Ekinci N, Tarhan MO. Coexistence of adenocarcinoma and neuroendocrine carcinoma in the stomach, a case report and review of the literature. Van Tıp Dergisi 2015;22(2):114-117.
D9. Cokmert S, Demir L, Akyol M. Flagellate-like hyperpigmentation following treatment with low-dose bleomycin: two case reports. Acta Oncologica Turcica 2015;48(3):134-138.
D10. Ulger E, Alacacioglu A, Gulseren AS, Zencir G, Demir L, Tarhan MO. Psychosocial problems in cancer and the importance of psychosocial oncology. DEÜ Tıp Fakültesi Dergisi 2014; 28(2): 85-92.
E. Papers presented at national scientific meetings and published in proceedings books:
E1. Demir L, Somali I, Erten C, Dirican A, Kucukzeybek Y, Can A, Tarhan MO. Our experience with Nordic-FLOX in the adjuvant treatment of colon cancer. 7th National Medical Oncology Congress, Proceedings Book, Poster presentation no: 55, 2010.
E2. Dirican A, Demir L, Erten C, Somali I, Can A, Kucukzeybek Y, Sari AA, Rezanko T, Dirican N, Yurtsever S, Tarhan MO. A case of synchronous gastrointestinal stromal tumor and squamous cell lung carcinoma. 7th National Medical Oncology Congress, Proceedings Book, Case no: 12, 2010.
E3. Demir L, Dirican A, Erten Ç, Somalı I, Can A, Öztop R, Tarhan MO. A case of malignant epithelioid hemangioendothelioma of the liver progressing under chemotherapy and interferon therapy. 7th National Medical Oncology Congress, Proceedings Book, Case no: 19, 2010.
E4. Demir L, Dirican A, Erten Ç, Somalı I, Can A, Öztop R, Ermete M, Kücukzeybek Y, Tarhan MO. Metastasis of renal cell carcinoma to the larynx and thyroid; report of 2 cases with metastasis developing years after nephrectomy. 7th National Medical Oncology Congress, Proceedings Book, Case no: 33, 2010.
E5. Demir L, Dirican A, Erten Ç, Yiğit S, Somalı I, Can A, Küçükzeybek Y, Tarhan MO. A case of ovarian cancer metastasizing to an intramammary lymph node. 7th National Medical Oncology Congress, Proceedings Book, Case no: 13, 2010.
E6. Yigit S, Demir L, Çabuk FK, Erten Ç. Effect of Bax and Bcl-2 expression on prognosis in ovarian surface epithelial tumors. 20th National Pathology Congress, Proceedings Book, P-287, 2010.
E7. Dirican A, Küçükzeybek Y, Demir L, Can A, Bayoğlu V, Somalı I, Erten Ç, Tarhan MO, Medeni M. One-day DCF regimen in patients with advanced-stage gastric cancer. 8th National Medical Oncology Congress, Proceedings Book, Paper 6, 2011.
E8. Demir L, Can A, Dirican A, Bayoğlu V, Sari AA, Küçükzeybek Y, Somalı I, Erten Ç, Tarhan MO. Coexistence of neurofibromatosis-I and gastrointestinal stromal tumor: Case report. 8th National Medical Oncology Congress, Case report 207, 2011.
E9. Dirican A, Küçükzeybek Y, Demir L, Can A, Bayoğlu İV, Somalı I, Erten Ç, Tarhan MO. Mediastinal primitive neuroectodermal tumor: case report and review of the literature. 8th National Medical Oncology Congress, Proceedings Book, S248, 2011.
E10. Dirican A, Kucukzeybek Y, Somali I, Erten C, Demir L, Can A, Bayoglu V, Yigit S, Cakalagaoglu F, Yetimalan H, Tarhan MO. Micrometastasis from invasive ductal breast carcinoma into a uterine leiomyoma under adjuvant tamoxifen therapy: Case report. 8th National Medical Oncology Congress, Proceedings Book, Case report 196, 2012.
E11. Dirican A, Kucukzeybek Y, Somali I, Erten Ç, Demir L, Can A, Bayoglu V, Ermete M, Altınboga AA, Tarhan MO. Cutaneous and subcutaneous metastases of bladder cancer: Case report. 8th National Medical Oncology Congress, Proceedings Book, Case report 195, 2011.
E12. Demir L, Yiğit S, Tarhan MO, Kusku F, Kocaağaoğlu F, Somalı I, Erten Ç. Clinicopathological significance of Bax and Bcl-2 expression and tumor lymphocyte infiltration in ovarian cancer. 8th National Medical Oncology Congress, Proceedings Book, Paper 98, 2011.
E13. Dirican A, Küçükzeybek Y, Somalı I, Erten Ç, Demir L, Can A, Bayoğlu V, Altınboğa AA, Tarhan MO. A case of cardiac rhabdomyosarcoma arising from the left atrium. 8th National Medical Oncology Congress, Proceedings Book, Case report 197, 2011.
E14. Cabuk FK, Yigit S, Demir L. Survivin and MMP-9 expression in surface epithelial carcinomas of the ovary. Türk Patoloji Dergisi 21st National Pathology Congress Proceedings, 21st National Pathology Congress, Oral presentation-20, 2011.
E15. Dirican A, Küçükzeybek Y, Somalı I, Erten Ç, Payzın KB, Demir L, Can A, Bayoğlu İV, Akyol M, Köseoğlu M, Tarhan MO. Prognostic and predictive significance of hematological parameters in patients with metastatic renal cell carcinoma treated with sunitinib after interferon alpha therapy. 4th Medical Oncology Congress, Speech Texts and Abstract Book, S296-297, 2012.
E16. Demir L, Can A, Dirican A, Bayoğlu V, Akyol M, Küçükzeybek Y, Erten Ç, Tarhan MO. Report of two cases of malignant hemangiopericytoma. 4th Medical Oncology Congress, Proceedings Book, EP-314, 2012.
E17. Demir L, Somalı I, Alacacıoğlu A, Erten C, Küçükzeybek Y, Can A, Dirican A, Bayoğlu V, Akyol M, Tarhan MO. Efficacy of the cisplatin-gemcitabine combination in breast cancer cases with brain metastases. 4th Medical Oncology Congress, Proceedings Book, S244-S245, 2012.
E18. Tarhan MO, Demir L, Akyol M, Erten Ç, Somalı I, Küçükzeybek Y, Can A, Dirican A, Bayoğlu V. Review of breast cancer patients with bone marrow metastases. 4th Medical Oncology Congress, Speech Texts and Abstract Book, S247-248, 2012.
E19. Küçükzeybek Y, Dirican A, Somalı I, Erten Ç, Demir L, Can A, Bayoğlu İV, Akyol M, Tarhan MO. Second-line irinotecan therapy in metastatic gastric cancer. 4th Medical Oncology Congress, Speech Texts and Abstract Book, S278, 2012.
E20. Bayoğlu V, Küçükzeybek Y, Demir L, Dirican A, Can A, Akyol M, Erten C, Tarhan MO. Drug eruption induced by gemcitabine; case report. 4th Medical Oncology Congress, Proceedings Book, EP-158, 2012.
E21. Demir L, Bayoğlu V, Can A, Dirican A, Akyol M, Küçükzeybek Y, Erten C, Tarhan MO. A case of metastatic colon adenocarcinoma presenting with synchronous tongue metastasis. 4th Medical Oncology Congress, Proceedings Book, EP-170, 2012.
E22. Akyol M, Dirican A, Demir L, Can A, Bayoğlu V, Küçükzeybek Y, Erten Ç, Tarhan MO. A case of colon cancer with skin and maxillary sinus metastases. 4th Medical Oncology Congress, Proceedings Book, EP-176, 2012.
E23. Dirican A, Küçükzeybek Y, Aydın A, Demir L, Can A, Bayoğlu V, Yurtsever S, Somalı I, Erten Ç, Akyol M, Tarhan MO. Neoadjuvant or adjuvant docetaxel-cisplatin chemotherapy in non-metastatic advanced-stage nasopharyngeal cancer. 4th Medical Oncology Congress, Proceedings Book, EP-352012, 2012.
E24. Bayoğlu İV, Küçükzeybek Y, Dirican A, Demir L, Can A, Akyol M, Somalı I, Tarhan MO. Renal cell carcinoma presenting with skeletal muscle metastasis: case report and review of the literature. 4th Medical Oncology Congress, Speech Texts and Abstract Book, S297, 2012.
E25. Dirican A, Küçükzeybek Y, Somalı I, Erten Ç, Payzın KB, Demir L, Can A, Bayoğlu İV, Akyol M, Köseoğlu M, Tarhan MO. Prognostic hematological parameters in metastatic renal cell carcinoma. 4th Medical Oncology Congress, Speech Texts and Abstract Book, S291-292, 2012.
E26. Akyol M, Dirican A, Demir L, Can A, Bayoğlu V, Küçükzeybek Y, Erten Ç, Tarhan MO. A case of metastatic insulinoma with symptom improvement under somatostatin analog and steroid therapy. 4th Medical Oncology Congress, Proceedings Book, EP-83, 2012.
E27. Çokmert S, Sarı A, Küçükzeybek Y, Demir L, Can A, Dirican A, Bayoğlu V, Akyol M, Erten Ç, Alacacıoğlu A, Tarhan O. Neuroendocrine carcinoma of the ampulla of Vater and incidental synchronous colon adenocarcinoma: case report. 9th National Medical Oncology Congress, Abstract Book, O41, 2012.
E28. Tarhan O, Demir L, Erten Ç, Ekinci N, Alacacıoğlu A, Somalı I, Peker Y, Küçükzeybek Y, Can A, Dirican A, Bayoğlu V, Akyol M. Prognostic and predictive significance of clinical and pathological features in patients with gastrointestinal stromal tumors. 9th National Medical Oncology Congress, Abstract Book, P77, 2012.
E29. Demir L, Yiğit S, Tarhan O, Erten Ç, Somalı I, Ellidokuz H, Küçükzeybek Y, Alacacıoğlu A, Can A, Dirican A, Bayoğlu V, Akyol M. The role of clinicopathological factors and T lymphocyte infiltration in response to neoadjuvant chemotherapy and survival in locally advanced breast cancer. 9th National Medical Oncology Congress, Abstract Book, P50, 2012.
E30. Tarhan MO, Gönel A, Küçükzeybek Y, Erten Ç, Çuhadar S, Yiğit SÇ, Atay A, Somalı I, Dirican A, Demir L, Köseoğlu M. Prognostic significance of serum CA15-3 level and circulating tumor cells in patients diagnosed with metastatic breast cancer. 20th National Cancer Congress, Book of Paper Abstracts, S73, 2013.
E31. Can A, Alacacıoğlu A, Küçükzeybek Y, Erten Ç, Çokmert S, Demir L, Dirican A, Bayoğlu V, Akyol M, Aslan F, Tarhan O. Relationship of insulin resistance and metabolic syndrome with prognostic factors of breast cancer in postmenopausal breast cancer. 20th National Cancer Congress, Book of Paper Abstracts, S86, 2013.
E32. Küçükzeybek Y, Akyol M, Dirican A, Demir L, Can A, Bayoğlu V, Çokmert S, Alacacıoğlu A, Erten Ç, Tarhan O. Efficacy of the Nordic cisplatin regimen in patients with metastatic esophageal carcinoma. 20th National Cancer Congress, Book of Paper Abstracts, S152, 2013.
E33. Can A, Aslan F, Alacacıoğlu A, Küçükzeybek Y, Erten Ç, Çokmert S, Demir L, Dirican A, Bayoğlu V, Akyol M, Tarhan O. Effect of metabolic syndrome and metabolic syndrome parameters on prognostic factors in newly diagnosed colon cancer patients. 20th National Cancer Congress, Book of Paper Abstracts, S132, 2013.
E34. Çokmert S, Dirican A, Demir L, Akyol M, Bayoğlu V, Can A, Küçükzeybek Y, Erten Ç, Tarhan MO. In metastatic colorectal cancer, the increase in mean corpuscular volume associated with capecitabine use may predict clinical response and survival. 20th National Cancer Congress, Book of Paper Abstracts, S124, 2013.
E35. Can A, Alacacıoğlu A, Küçükzeybek Y, Erten Ç, Çokmert S, Demir L, Dirican A, Bayoğlu V, Akyol M, Aslan F, Tarhan O. Ocular metastasis in breast cancer: case report. 20th National Cancer Congress, Book of Paper Abstracts, S114, 2013.
E36. Akyol M, Küçükzeybek Y, Demir L, Can A, Dirican A, Bayoğlu V, Çokmert S, Alacacıoğlu A, Erten Ç, Tarhan O. Gastrointestinal stromal tumor and metachronous lung mucinous adenocarcinoma. 20th National Cancer Congress, Book of Paper Abstracts, S156, 2013.
E37. Akyol M, Küçükzeybek Y, Demir L, Can A, Dirican A, Bayoğlu V, Çokmert S, Alacacıoğlu A, Erten Ç, Tarhan O. Case report of sacrococcygeal chordoma with liver metastasis. 20th National Cancer Congress, Book of Paper Abstracts, S281, 2013.
E38. Can A, Alacacıoğlu A, Küçükzeybek Y, Erten Ç, Çokmert S, Demir L, Dirican A, Bayoğlu V, Akyol M, Aslan F, Tarhan O. Pilomatricoma in the parotid region: case report. 20th National Cancer Congress, Book of Paper Abstracts, S254, 2013.
E39. Can A, Alacacıoğlu A, Küçükzeybek Y, Erten Ç, Çokmert S, Demir L, Dirican A, Bayoğlu V, Akyol M, Aslan F, Tarhan O. Hepatoid carcinoma of the stomach: case report. 20th National Cancer Congress, Book of Paper Abstracts, S170, 2013.
E40. Küçükzeybek Y, Akyol M, Bayoğlu V, Ekinci N, Can A, Dirican A, Alacacıoğlu A, Erten Ç, Demir L, Çokmert S, Tarhan O. Adenocarcinoma and neuroendocrine carcinoma in the stomach, case report. 20th National Cancer Congress, Book of Paper Abstracts, S170, 2013.
E41. Küçükzeybek Y, Dirican A, Kücükzeybek BB, Akyol M, Bayoğlu İV, Can A, Çokmert S, Demir L, Erten Ç, Öztop RMT, Tarhan MO. Ovarian cancer metastasis to an intramammary lymph node, case report. 20th National Cancer Congress, Book of Paper Abstracts, S231-231, 2013.
E42. Dirican A, Alacacıoğlu A, Küçükzeybek Y, Koyuncu B, Erten Ç, Somalı I, Can A, Bayoğlu V, Akyol M, Demir L, Yiğit S, Tarhan O. Do the neutrophil/lymphocyte ratio and the derived neutrophil/lymphocyte ratio predict prognosis in breast cancer? 20th National Cancer Congress, Book of Paper Abstracts, S77, 2013.
E43. Demir L, Yiğit S, Tarhan MO, Erten Ç, Akyol M, Can A, Dirican A, Bayoğlu V, Küçükzeybek Y, Alacacıoğlu A, Çakalağaoğlu F. The role of ER/PR, HER2 and EGFR receptor expression in response to chemotherapy and survival in epithelial ovarian cancer. 10th National Medical Oncology Congress, Abstract Book, P43, 2013.
E44. Demir L, Ekinci N, Tarhan MO, Erten Ç, Somali I, Can A, Dirican A, Bayoğlu V, Akyol M, Küçükzeybek Y, Alacacıoğlu A. Effect of cyclin D1, cyclin A, P53 and Ki67 proliferation status on prognosis and survival in early-stage colon cancer. 10th National Medical Oncology Congress, Abstract Book, P44, 2013.
E45. Çokmert S, Demir L, Bayoğlu V, Akyol M, Can A, Dirican A, Küçükzeybek Y, Alacacıoğlu A, Erten Ç, Tarhan MO. SUVmax value measured by FDG PET CT is associated with molecular subgroups in patients with metastatic breast cancer and may predict survival. 10th National Medical Oncology Congress, Abstract Book, P106, 2013.
E46. Dirican A, Varol U, Küçükzeybek Y, Alacacıoğlu A, Erten Ç, Somali I, Can A, Demir L, Bayoğlu V, Akyol M, Yıldız Y, Koyuncu B, Çoban E, Tarhan MO. First-line chemotherapy with and without bevacizumab in patients with metastatic colorectal cancer: Does the neutrophil/lymphocyte ratio predict the efficacy of bevacizumab therapy? 10th National Medical Oncology Congress, Abstract Book, P2, 2013.
E47. Kaplan MA, Işıkdoğan A, Koca D, Küçüköner M, Gümüşsoy Ö, Yıldız R, Dayan A, Demir L, Geredeli Ç, Koçer M, Arslan ÜY, İnal A, Ünal OÜ, Mert AG,Bilici M, Özkan M, Elkıran AT, Yaman Ş, Durnalı AG, Süner A, Alıcı S, Tarhan MO, Börüban C, Urakçı Z, Büyükberber S. Contribution of systemic therapy to survival according to biological subtypes in breast cancer patients with brain metastases (ATOD Study). 9th National Medical Oncology Congress, Abstract Book, A13, 2012.
E48. Dirican A, Akyol M, Alacacıoğlu A, Küçükzeybek Y, Erten Ç, Somalı I, Çokmert S, Demir L, Can A, Bayoğlu V, Tarhan O. Relationship of peripheral hematological parameters with prognosis in patients with gastric cancer. 9th National Medical Oncology Congress, Abstract Book, P4, 2012.
E49. Demir L, Yigit S, Tarhan MO, Erten Ç, Somalı I, Ellidokuz H, Küçükzeybek Y, Alacacıoğlu A, Can A, Dirican A, Bayoglu V, Akyol M. The role of clinicopathological factors and T lymphocyte infiltration in response to neoadjuvant chemotherapy and survival in locally advanced breast cancer. 9th National Medical Oncology Congress, Abstract Book, P50, 2012.
E50. Tarhan O, Ülger WE, Zencir G, Demir L, Dirican A, Alacacıoğlu A, Somalı I, Erten Ç, Varol Ş, Şeşoğulları O. Factors affecting depression, anxiety and hopelessness in cancer patients. 9th National Medical Oncology Congress, Abstract Book, P76, 2012.
E51. Çokmert S, Yavuzşen T, Ellidokuz H, Küçükzeybek Y, Demir L, Can A, Dirican A, Bayoğlu V, Akyol M, Erten Ç, Alacacıoğlu A, Tarhan O. Activity choices of outpatient cancer patients during chemotherapy: Results of a survey study. 9th National Medical Oncology Congress, Abstract Book, P102, 2012.
E52. Akyol M, Bayoğlu V, Demir L, Can A, Dirican A, Çokmert S, Alacacıoğlu A, Küçükzeybek Y, Erten Ç, Tarhan O. A case of metastatic melanoma responsive to low-dose temozolomide therapy. 9th National Medical Oncology Congress, Abstract Book, O29, 2012.
E53. Çokmert S, Dolapçıoğlu M, Bahadır F, Küçükzeybek Y, Demir L, Can A, Dirican A, Bayoğlu V, Akyol M, Erten Ç, Alacacıoğlu A, Tarhan O. Wedge resection of a duodenal gastrointestinal stromal tumor: case report. 9th National Medical Oncology Congress, Abstract Book, O40, 2012.
E54. Çokmert S, Bolat F, Demir L, Küçükzeybek Y, Can A, Dirican A, Bayoğlu V, Akyol M, Erten Ç, Alacacıoğlu A, Tarhan O. Leiomyosarcoma of the clitoris. 9th National Medical Oncology Congress, Abstract Book, O66, 2012.
E55. Çokmert S, Bahadır F, Demir L, Küçükzeybek Y, Can A, Dirican A, Bayoğlu V, Akyol M, Erten Ç, Alacacıoğlu A, Tarhan O. Bleomycin-induced flagellate-like hyperpigmentation in a patient with Hodgkin lymphoma. 9th National Medical Oncology Congress, Abstract Book, O69, 2012.
E56. Çokmert S, Bahadır F, Dolapçıoğlu M, Yavuz M, Topkan E, Küçükzeybek Y, Demir L, Can A, Dirican A, Bayoğlu V, Akyol M, Erten Ç, Alacacıoğlu A, Tarhan O. Surgical treatment of a giant retroperitoneal benign schwannoma combined with preoperative radiotherapy. 9th National Medical Oncology Congress, Abstract Book, O70, 2012.
E57. Bayoğlu V, Varol U, Yıldız I, Küçükzeybek Y, Alacacıoğlu A, Dirican A, Demir L, Can A, Akyol M, Yıldız Y, Tarhan MO. Evaluation of the efficacy and toxicity of uracil/tegafur/leucovorin combination therapy in patients with metastatic colorectal cancer who have received multiple lines of treatment. 5th Medical Oncology Congress, Congress Book, S455, 2014.
E58. Bayoğlu V, Varol U, Yıldız I, Kücükzeybek Y, Alacacıoğlu A, Demir L, Dirican A, Akyol M, Yıldız Y, Karabulut B, Uslu R, Tarhan MO. Evaluation of second-line XELOX chemotherapy in patients with locally advanced-metastatic pancreatic cancer. 5th Medical Oncology Congress, Congress Book, S429, 2014.
E59. Akyol M, Bayoğlu V, Yıldız Y, Varol U, Yıldız İ, Demir L, Çokmert S, Alacacıoğlu A, Küçükzeybek Y, Tarhan MO. Case report of a young patient with omental extragastrointestinal stromal tumor. 2nd Aegean Hematology Oncology Symposium, Proceedings Book, S92, 2014.
E60. Dirican A, Küçükzeybek Y, Alacacıoğlu A, Varol U, Aksun S, Demir L, Çoban E, Sütçü R, Tarhan MO. Effect of pre-angiogenic factors on the outcomes of bevacizumab therapy in patients with metastatic colorectal cancer. 5th Medical Oncology Congress, Congress Book, S306, 2014.
E61. Akyol M, Demir L, Bayoğlu V, Yıldız Y, Dirican A, Çokmert S, Küçükzeybek Y, Alacacıoğlu A, Tarhan MO. Poorly differentiated carcinoma of the orbit. 5th Medical Oncology Congress, Congress Book, S365, 2014.
E62. Demir L. Comparison of concurrent docetaxel and castration therapy with castration alone in hormone-sensitive metastatic prostate cancer; single-center experience. Presented as an oral presentation at the 4th National Urogenital Cancers Congress and published in full text in the congress proceedings book (S5 30 September-4 October 2020).
E63. Demir L. Treatment of advanced-stage non-seminomatous testicular cancers and the role of PET-CT: case presentation (presented orally at the 3rd National Urogenital Cancers Congress and published in full text). Journal of Human Rhytm 2020 Congress Special Issue. 2020;volume/vol 6. p:50
E64. Demir L. Evaluation of the efficacy and tolerability of Sunitinib and Pazopanib in metastatic renal cell cancer according to risk groups: single-center experience (oral presentation) 2nd Eskişehir Oncology Days, S-023. 5-7 April 2019.
E65. Demir N, Bayır D, Ersoy M, Demir L, Yıldız B, Dinçer M. Retrospective analysis of 8 cases of metastatic medullary thyroid carcinoma (oral presentation and abstract presentation). 6th Multidisciplinary Head and Neck Cancers Congress O-18. 5-8 March 2020, Antalya
E66. Garbioğlu DB, Demir N, Ersoy M, Yıldız B, Demir L, Şaylısoy S, Dinçer M. Evaluation of the treatment results and side effects of first-line platinum-5-fluorouracil-cetuximab therapy in patients with recurrent/metastatic head and neck cancer, single-center experience (oral presentation and abstract presentation). 6th Multidisciplinary Head and Neck Cancers Congress, O-16, 5-8 March 2020.
E67. Oktay E, Oflazoğlu U, Varol Y, Tanrıverdi Ö, Mermur N, Arda HÜ, Demir L, Keskin Ö, Somalı I, Öztop İ, Meydan N. Prognostic significance of TTF-1 in lung adenocarcinoma cases (oral presentation) Muğla Multidisciplinary Oncological Research Symposium 13-15 October 2017, s-03.
E68. Bayoğlu İV, Kurtel G, Alacacıoğlu A, Varım C, Yıldız İ, Küçükzeybek Y, Akyol M, Demir L, Dirican A, Yıldız Y, Tarhan MO. Prognostic significance of the neutrophil/lymphocyte ratio as a new biomarker in melanoma. S31. 21st National Cancer Congress, 22-26 April 2015.
E69. Bayır D, Ersoy M, Demir N, Demir L, Yıldız B, Dinçer M. Aggressive prostate cancer at a young age: a report of 2 cases. P-010. 2nd Eskişehir Oncology Days, 5-7 April 2019, Eskişehir.
E70. Ersoy M, Yıldız B, Junushova B, Demir L, Dinçer M. A case of gallbladder cancer presenting with muscle and skin metastases. Ep-226. 7th Turkish Medical Oncology Congress, 21-25 March 2018, Antalya.
E71. Ersoy M, Demir L, Yıldız B, Junushova B, Dinçer M. Two cases of intracranial hemangiopericytoma with visceral metastasis. EP-034. 7th Turkish Medical Oncology Congress, 21-25 March 2018, Antalya.
E72. Ersoy M, Demir L, Yıldız B, Junushova B, Dinçer M. Three cases of renal cell carcinoma that developed hyponatremia after pazopanib. EP-154. 7th Turkish Medical Oncology Congress, 21-25 March 2018, Antalya.
E73. Akyol M, Ülger E, Alacacıoğlu A, Küçükzeybek Y, Yıldız Y, Bayoğlu V, Gmüş Z, Yıldız İ, Salman T, Varol U, Demir L, Dirican A, Kara M, Ayakdaş S, Trahan MO. Anxiety, depression, quality of life and sexual dysfunction in Turkish patients with colorectal cancer (Izmir Oncology Group). P424. 21ST NATIONAL CANCER CONGRESS, 22-26 April 2015, Antalya
E74. Akyol M, Demir Leyla, Alacacıoğlu A, Kara M, Ellidokuz H, Küçükzeybek Y, Yıldız Y, Gümüş Z, Bayoğlu V, Yıldız İ, Salman T, Varol U, Küçükzeybek B, Demir L, Dirican A, Sütcü R, Tarhan MO. Effects of adjuvant chemotherapy on serum ADMA, endothelin-1 and body composition in patients with early-stage breast cancer. P36. 12th National Medical Oncology Congress, 16-20 September 2015.
E75. Alacacıoğlu A, Ülger E, Varol U, Yıldız İ, Salman T, Bayoğlu V, Dirican A, Demir L, Akyol M, Yıldız Y, Küçükzeybek Y, Alacacıolu İ, Tarhan MO. Effects of tamoxifen therapy on anxiety, quality of life and sexual satisfaction in premenopausal breast cancer patients. p76. XI. National Medical Oncology Congress. 17-21 September 2014, Cyprus.
E76. Akyol M, Ülger E, Alacacıoğlu A, Küçükzeybek Y, Demir L, Bayoğlu V, Yıldız Y, Gümüş ZZ, Yıldız Y, Salman T, Varol U, Dirican A, Çokmert S, Can A, Ayakdaş S, Can H, Tarhan MO. Quality of life in patients with colorectal cancer in Turkey. P50. XI. National Medical Oncology Congress, 17-21 September 2014, Cyprus
E77. Demir L, Gülpek D, Sağlam G, Ülger E, Akyol M, Çokmert S, Dirican A, Bayoğlu V, Yücel A, Alacacıoğlu A, Küçükzeybek Y, Tarhan MO. The relationship between breast cancer, cytokines and depression/anxiety. P42. XI. National Medical Oncology Congress, 17-21 September 2014, Cyprus.
E78. Akcay M, Etiz D, Demir L, Pınarbaşlı Ö, Özen A, Gürbüz MK. Malignant paraganglioma of the head and neck, case report (poster presentation). 6th Multidisciplinary Head and Neck Cancers Congress, p-07. 5-8 March 2020, Antalya
E79. Akyol M, Gümüş ZZ, Alacacıoğlu A, Küçükzeybek Y, Yıldız Y, Bayoğlu V, Demir L, Yıldız İ, Salman T, Varol U, Dirican A, Çokmert S, Can A, Yılmaz H, Rezanko TA, Ayakdaş S, Can H, Tarhan MO. Rare tumor associations in a patient diagnosed with Neurofibromatosis Type I: a case report. O93. XI. National Medical Oncology Congress, 17-21 September 2014, Cyprus.
E80. Mustafa Ersoy, Duygu Bayır, Nazan Demir, Lütfiye Demir, Bülent Yıldız, Murat Dinçer. Clinical course of 3 patients diagnosed with anaplastic thyroid cancer followed at Eskişehir Osmangazi University Faculty of Medicine. 6th Multidisciplinary Head and Neck Cancers Congress, p-10. 5-8 March 2020, Antalya
E81. Bali N, Yıldız B, Junushova B, Dal P, Aliyev A, Paşaoğlu Ö, Erkasap S, Demir L, Dinçer M. Clinical and pathological parameters affecting surgical margin proximity/positivity in patients operated for breast cancer. P-059. 22nd National Cancer Congress, 19-23 April 2017, Antalya.
E82. Ersoy M, Demir L, Junushova B, Yıldız B, Dinçer M. Symptomatic bradycardia associated with 5-fluorouracil. EP-235. 7th Turkish Medical Oncology Congress, 21-25 March 2018.
E83. Aliyev A, Dal P, Junushova B, Musmul A, Yıldız B, Demir L, Dinçer M. Clinical characteristics and prognostic factors of patients with hepatocellular carcinoma followed at the Eskişehir Osmangazi University Prof. Dr. Servet Bilir Oncology Center. P-547. 22nd National Cancer Congress, 19-23 April 2017, Antalya.
English